96939 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION
#2GDNF FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#3NUCLEIC ACID CONSTRUCT FOR ACHIEVING MODULAR LOADING OF ENGINEERED EVS FUNCTIONAL PROTEIN AND USE OF SAID CONSTRUCT
#4METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH COMPRISING GDNF ADMINISTRATION
#5METHODS OF TREATING FIBROSIS AND ARRHYTHMIA WITH A NEUREGULIN-1 FUSION PROTEIN
#6METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH COMPRISING GDNF ADMINISTRATION
#7CHIMERIC PROTEINS FOR TREATMENT OF ACUTE RADIATION SYNDROME
#8NEUREGULIN-4 COMPOUNDS AND METHODS OF USE
#9COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE
#10COMPOSITIONS AND METHODS FOR SPATIAL AND TEMPORAL CONTROL OF NEUROTROPHIC GROWTH FACTOR EXPRESSION
#11GDNF FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#12METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH
#13CORTICAL NEURAL PROGENITOR CELLS FROM IPSCS
#14HUMAN NEUREGULIN-1 (NRG-1) RECOMBINANT FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
#15CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING
#16Cell Lines Secreting Alpha-Synuclein Targeting Antibodies, Progranulin and Prosaposin and a Complex of Both, and GDNF
#17Recombinant Human Neuregulin Derivatives and Use Thereof
#18Compositions and methods for treating heart failure
#19Neuregulin-4 compounds and methods of use
#20Methods for promoting wound healing and hair growth comprising GDNF administration
#21METHOD AND KIT FOR TREATING A NEURODEGENERATIVE DISEASE
#22METHODS FOR TREATING CARDIAC INJURY
#23Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereof
#24COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN DIABETIC PATIENTS
#25METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS
#26Method of effecting neuroprotection using soluble neuregulin isoforms
#27Methods and compositions for inducible expression of neurotrophic factors
#28METHODS FOR CARDIOMYOCYTE SURVIVAL, PROLIFERATION OR DIFFERENTIATION BY NRG-2
#29Neuregulin-4 compounds and methods of use
#30HSA-GDF-15 FUSION POLYPEPTIDE AND USE THEREOF
#31METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH
#32Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction
#33COMPOSITION COMPRISING NEUREGULIN FOR ORGAN PERFUSION, PRESERVATION OR REPERFUSION, AND USE THEREOF
#34Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereof
#35Method of effecting neuroprotection using soluble neuregulin isoforms
#36METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH
#37GDNF fusion polypeptides and methods of use thereof
#38Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2
#39SUPPRESSION OF CANCER
#40Artificial synapse inducer and method of making the same
#41Hydrogel microparticle scaffold with gradients of degradability and methods thereof
#42METHODS FOR TREATING CARDIAC INJURY
#43TARGETING TRASTUZUMAB-RESISTANT HER2+ BREAST CANCER WITH A HER3-TARGETING NANOPARTICLE
#44Hydrogel microparticle scaffold with gradients of degradability and methods thereof
#45Self-assembling complex for targeting chemical agents to cells
#46NEUREGULIN BASED METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES
#47CHIMERIC PROTEIN
#48Compositions and methods for treating heart failure
#49Method of effecting neuroprotection using soluble Neuregulin isoforms
#50NOVEL FUSION GENES AS FACTORS RESPONSIBLE FOR GASTRIC CANCER
#51NRG1 fusion genes in cancer
#52Neuregulin variants and methods of screening and using thereof
#53SYNAPTOGENIC PROTEIN TAGGED WITH BIOTIN AND RECONSTITUTION OF ARTIFICIAL SYNAPSE BY USING SAME
#54NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE
#55Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle
#56Methods for promoting wound healing and hair growth comprising GDNF administration
#57Neuregulin peptides and their use
#58Self-assembling complex for targeting chemical agents to cells
#59Compositions and methods for treating heart failure in diabetic patients
#60Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
#61ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS
#62Neurturin molecules
#63CHIMERIC NEUREGULINS AND METHOD OF MAKING AND USE THEREOF
#64NEUREGULIN ISOFORMS, NEUREGULIN POLYPEPTIDES AND USES THEREOF
#65Neuregulin based methods and compositions for treating cardiovascular diseases
#66NOVEL FUSION GENES IDENTIFIED IN LUNG CANCER
#67METHOD OF INHIBITING DOPAMINERGIC CELL DEATH
#68Suppression of cancer
#69Neuregulin peptides and their use
#70Chimeric neuregulins and method of making and use thereof
#71Neuregulin variants and methods of screening and using thereof
#72NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE
#73Regulation of skin pigmentation by neuregulin-1 (NRG-1)
#74Polymer-conjugated glycosylated neublastin
#75NOVEL NEUROTROPHIC FACTORS
#76METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2
#77FUSION PROTEINS FOR DELIVERY OF GDNF AND BDNF TO THE CENTRAL NERVOUS SYSTEM
#78Signature Of Secreted Protein Isoforms Specific To Ovarian Cancer
#79Neuronal differentiation-inducing peptide and use thereof
#80NEURAL REGENERATION PEPTIDES AND METHODS FOR THEIR USE IN TREATMENT OF BRAIN DAMAGE
#81SUPPRESSION OF CANCER
#82Use of neuregulin-β as an indicator and/or target
#83GROWTH FACTOR WHICH ACTS THROUGH ERB B-4 RTK
#84Neuregulin peptides and their use
#85Neuregulin antagonists and use thereof in treating cancer
#86Methods for treating muscle diseases and disorders
#87Neuregulin based methods and compositions for treating cardiovascular disease
#88Production of glycosylated polypeptides in micro algae
#89Neurturin conjugates for pharmaceutical use
#90Self-assembling complex for targeting chemical agents to cells
#91ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS
#92Novel Neurotrophic Factors
#93Antibodies to human ErbB4
#94ErbB2 and ErbB3 chimeric heteromultimer receptors
#95Neural regeneration peptides and formulations thereof
#96Growth factor which acts through ErbB-4 RTK
#97Neuregulin-β isoform
#98Glial mitogenic factors, their preparation and use
#99Neuregulin variants and methods of screening and using thereof
#100USE OF NEUREGULIN FOR ORGAN PRESERVATION
#101Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
#102ErbB4 antagonists
#103GAMMA-HEREGULIN
#104Methods for treating muscle diseases and disorders
#105Diagnostic and Therapeutic Use of a Novel Growth Factor, Neublasmin
#106Polymer conjugates of mutated neublastin
#107Neuregulin-1 transgenic mouse and methods of use
#108Heregulin-like Factor
#109Glial mitogenic factors, their preparation and use
#110Novel Neurotrophic Factors
#111Hybrid proteins with ErbB4 extracellular domain and neuregulin heparin-binding domain for targeting
#112Materials and Methods for Modulating Cell Motility
#113Neublastin variants
#114Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
#115EGFH2 genes and gene products
#116Amino Acid Sequences Essential to Neuron Specific Gene Expression
#117Polymer conjugated glycosylated neublastin
#118Neuregulin variants and methods of screening and using thereof
#119Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
#120ErbB4 antagonists
#121Chimeric Heteromultimer Adhesins
#122Recombinant chimeric acetylcholine receptors and their derivatives recognized by CD4 T cells of myasthenic patients for the treatment of myasthenia gravis
#123Methods of stimulating ErbB4 receptor phosphorylation
#124Neuregulin protein regulation of synaptic proteins
#125Growth factor with acts through Erb B-4 RTK
#126Gdnf-related neuropeptides
#127Novel polynuceotides and polypeptides encoded thereby
#128Heregulin variants
#129Pan-HER antagonists and methods of use
#130Chimeric protein
#131Heregulin-like factor
#132Polynucleotides encoding polypeptides that bind to the P185receptor
#133ErbB4 antagonists
#134ErbB4 receptor-specific neuregulin related ligands and uses therefor
#135γ-heregulin
#136Neuregulin based methods and compositions for treating cardiovascular diseases
#137Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
#138Human schizophrenia gene
#139Antibodies to EGFH2 polypeptides
#140Neublastin expression constructs
#141Polymer conjugates of mutated neublastin
#142ErbB4 receptor-specific neuregulin related ligands and uses therefor
#143Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
#144Glial mitogenic factors, their preparation and use
#145Secretion of neublastin
#146ErbB4 receptor-specific neuregulin related ligands and uses therefor
#147Prognostic evaluation of cancer